BCL2L1 and neoplasm: In order to phenocopy increased apoptotic priming that is found in pre-malignant and tumor cells, we co-treated cells with ABT-737, a BH3-mimetic compound that selectively neutralizes anti-apoptotic BCL-2, BCL-xL, and BCL-w (Oltersdorf et al., 2005).